$24.38
Live
0.08%
Downside
Day's Volatility :0.77%
Upside
0.69%
8.12%
Downside
52 Weeks Volatility :34.25%
Upside
28.44%
Period | Rentokil Initial Plc - Adr | Index (Russel 2000) |
---|---|---|
3 Months | -22.25% | 0.0% |
6 Months | -7.69% | 0.0% |
1 Year | -12.67% | 0.0% |
3 Years | -8.2% | -23.0% |
Market Capitalization | 12.3B |
Book Value | $1.65 |
Dividend Share | 0.091 |
Dividend Yield | 2.54% |
Earnings Per Share (EPS) | 1.01 |
PE Ratio | 24.32 |
PEG Ratio | 0.55 |
Wall Street Target Price | 32.29 |
Profit Margin | 7.25% |
Operating Margin TTM | 13.3% |
Return On Assets TTM | 4.11% |
Return On Equity TTM | 9.66% |
Revenue TTM | 5.4B |
Revenue Per Share TTM | 10.74 |
Quarterly Revenue Growth YOY | 1.3% |
Gross Profit TTM | 536.0M |
EBITDA | 1.1B |
Diluted Eps TTM | 1.01 |
Quarterly Earnings Growth YOY | 0.06 |
EPS Estimate Current Year | 0.69 |
EPS Estimate Next Year | 0.61 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 32.44%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 3.1B | ↑ 2.49% |
Net Income | -124.5M | ↓ 114.4% |
Net Profit Margin | -3.98% | ↓ 32.28% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 3.5B | ↑ 8.25% |
Net Income | 371.6M | ↓ 388.71% |
Net Profit Margin | 10.6% | ↑ 14.58% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 3.7B | ↑ 4.23% |
Net Income | 249.8M | ↓ 34.46% |
Net Profit Margin | 6.67% | ↓ 3.93% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 3.9B | ↑ 5.9% |
Net Income | 349.9M | ↑ 41.4% |
Net Profit Margin | 8.9% | ↑ 2.23% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 4.5B | ↑ 25.73% |
Net Income | 282.4M | ↓ 11.79% |
Net Profit Margin | 6.25% | ↓ 2.65% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 6.8B | ↑ 44.72% |
Net Income | 482.3M | ↑ 64.22% |
Net Profit Margin | 7.09% | ↑ 0.84% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 899.8M | - |
Net Income | 80.1M | - |
Net Profit Margin | 8.9% | - |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.6B | ↑ 189.78% |
Net Income | 130.8M | ↑ 63.83% |
Net Profit Margin | 5.03% | ↓ 3.87% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 3.4B | ↑ 24.7% |
Net Income | 233.6M | ↑ 71.61% |
Net Profit Margin | 6.93% | ↑ 1.9% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.7B | ↑ 1.24% |
Net Income | 196.0M | ↑ 5.95% |
Net Profit Margin | 7.25% | ↑ 0.32% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 2.7B | ↑ 0.07% |
Net Income | 196.0M | ↑ 0.0% |
Net Profit Margin | 7.24% | ↓ 0.01% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 3.9B | ↓ 0.84% |
Total Liabilities | 2.8B | ↑ 3.46% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 5.6B | ↑ 38.05% |
Total Liabilities | 4.3B | ↑ 44.59% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 7.5B | ↑ 31.24% |
Total Liabilities | 6.0B | ↑ 36.93% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 5.8B | ↓ 22.57% |
Total Liabilities | 4.1B | ↓ 31.29% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 14.5B | ↑ 175.77% |
Total Liabilities | 9.5B | ↑ 155.75% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 14.1B | ↓ 6.67% |
Total Liabilities | 8.9B | ↓ 10.03% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 14.5B | - |
Total Liabilities | 9.5B | - |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 14.5B | ↑ 0.0% |
Total Liabilities | 9.5B | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 13.9B | ↓ 7.8% |
Total Liabilities | 8.9B | ↓ 10.02% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 14.1B | ↑ 1.23% |
Total Liabilities | 8.9B | ↓ 0.01% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 11.2B | ↑ 0.94% |
Total Liabilities | 7.1B | ↑ 0.43% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 460.5M | ↓ 4.27% |
Investing Cash Flow | -578.5M | ↑ 3050.34% |
Financing Cash Flow | -146.5M | ↓ 29.71% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 606.1M | ↑ 27.31% |
Investing Cash Flow | -80.0M | ↓ 86.62% |
Financing Cash Flow | -289.7M | ↑ 91.27% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 718.8M | ↑ 15.6% |
Investing Cash Flow | -668.3M | ↑ 714.24% |
Financing Cash Flow | 340.5M | ↓ 214.55% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 749.3M | ↑ 5.25% |
Investing Cash Flow | -586.8M | ↓ 11.34% |
Financing Cash Flow | -554.9M | ↓ 264.54% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 730.4M | ↑ 6.53% |
Investing Cash Flow | -1.5B | ↑ 171.37% |
Financing Cash Flow | 1.6B | ↓ 417.19% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 192.3M | ↓ 35.2% |
Investing Cash Flow | -560.7M | ↑ 373.83% |
Financing Cash Flow | -83.7M | ↓ 105.02% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 171.4M | ↓ 16.91% |
Investing Cash Flow | -1.5B | ↑ 142.21% |
Financing Cash Flow | 1.6B | ↓ 1892.68% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 419.2M | ↓ 3.07% |
Investing Cash Flow | -347.3M | - |
Financing Cash Flow | -272.8M | ↑ 46.34% |
Sell
Neutral
Buy
Rentokil Initial Plc - Adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Rentokil Initial Plc - Adr | 1.73% | -7.69% | -12.67% | -8.2% | -8.2% |
Copart, Inc. | 4.24% | 1.09% | 22.04% | 41.94% | 157.74% |
Thomson Reuters Corp. | -1.82% | 10.2% | 36.86% | 42.25% | 151.19% |
Global Payments Inc. | -7.81% | -17.64% | -5.95% | -36.05% | -36.59% |
Rb Global Inc | -3.86% | 11.38% | 29.57% | 20.54% | 101.97% |
Cintas Corporation | 4.92% | 28.73% | 71.39% | 101.6% | 217.08% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Rentokil Initial Plc - Adr | 24.32 | 24.32 | 0.55 | 0.69 | 0.1 | 0.04 | 0.03 | 1.65 |
Copart, Inc. | 38.35 | 38.35 | 3.01 | 1.44 | 0.2 | 0.13 | NA | 7.81 |
Thomson Reuters Corp. | 32.74 | 32.74 | 3.64 | 3.76 | 0.2 | 0.06 | 0.01 | 25.83 |
Global Payments Inc. | 18.77 | 18.77 | 0.39 | 11.58 | 0.06 | 0.03 | 0.01 | 88.02 |
Rb Global Inc | 44.25 | 44.25 | 0.71 | 4.57 | 0.07 | 0.04 | 0.01 | 27.98 |
Cintas Corporation | 54.05 | 54.05 | 4.65 | 14.95 | 0.4 | 0.15 | 0.01 | 9.97 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Rentokil Initial Plc - Adr | Buy | $12.3B | -8.2% | 24.32 | 7.25% |
Copart, Inc. | Buy | $51.7B | 157.74% | 38.35 | 32.17% |
Thomson Reuters Corp. | Hold | $76.1B | 151.19% | 32.74 | 33.65% |
Global Payments Inc. | Buy | $26.0B | -36.59% | 18.77 | 14.26% |
Rb Global Inc | Buy | $14.8B | 101.97% | 44.25 | 8.68% |
Cintas Corporation | Buy | $86.3B | 217.08% | 54.05 | 16.8% |
Insights on Rentokil Initial Plc - Adr
In the last 1 year, Cintas Corporation has given 71.8% return, outperforming this stock by 83.1%
HHG PLC
Gates Capital Management Inc
Brown Advisory Holdings Inc
Schroder Investment Management Group
Aristotle Capital Management LLC
ClearBridge Advisors, LLC
In the quarter ending September,2024. Rentokil Initial Plc - Adr has declared dividend of $0.37
Read MoreRentokil Initial Plc engages in the provision of business support services. The firms products and services protect people from pest-borne disease and the risks of poor hygiene.
Organization | Rentokil Initial Plc - Adr |
Employees | 62931 |
CEO | Mr. Andrew M. Ransom |
Industry | Services |